Bvf Inc/IL
$3.9B 13F equity value
46 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Bvf Inc/IL covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 2,965,160 | $555M | 14.2% |
| KYMR | KYMERA THERAPEUTICS INC | 3,872,052 | $444M | 11.4% |
| XOMA | XOMA ROYALTY CORPORATION | 7,593,303 | $323M | 8.3% |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 16,001,284 | $312M | 8.0% |
| GHRS | GH RESEARCH PLC | 8,650,158 | $233M | 5.9% |
| GPCR | STRUCTURE THERAPEUTICS INC | 3,366,823 | $181M | 4.6% |
| NKTR | NEKTAR THERAPEUTICS | 2,391,075 | $167M | 4.3% |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,056,027 | $124M | 3.2% |
| XNCR | XENCOR INC | 7,133,720 | $115M | 2.9% |
| ALKS | ALKERMES PLC | 2,154,704 | $113M | 2.9% |
Track Bvf Inc/IL's 13F portfolio: $3.9B in reported holdings, 46 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}